Covid-19 roundup: Eli Lil­ly de­clares suc­cess on JAK block­er in NIH tri­al; UK gives small biotech a big vac­cine deal

The NIH-led study that gave the world the first pos­i­tive, ran­dom­ized remde­sivir re­sult has come back with a sec­ond one, show­ing that, when com­bined with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.